By Denny Jacob
Allurion Technologies shares rose after agreeing to a private placement with expected gross proceeds of $2.5 million that will extend its runway through early 2026.
The stock was up 13% to $3.37. The stock is down 96% in the last 52 weeks.
The developer of obesity treatments entered into a subscription agreement with funds affiliated with RTW Investments for the purchase and sale of 841,751 shares of its common stock at a purchase price of $2.97 a share. The agreement also includes an option to fund up to an additional $10 million in subsequent tranches.
The private placement is expected to close on or about Wednesday.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
January 14, 2025 13:42 ET (18:42 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。